Sequenom Revenue and Competitors

Boston, MA USA

Location

$185.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sequenom's estimated annual revenue is currently $300M per year.(i)
  • Sequenom's estimated revenue per employee is $1,764,706
  • Sequenom's total funding is $185.3M.

Employee Data

  • Sequenom has 170 Employees.(i)
  • Sequenom grew their employee count by 3% last year.

Sequenom's People

NameTitleEmail/Phone
1
Senior DirectorReveal Email/Phone
2
Clinical Laboratory DirectorReveal Email/Phone
3
Billing Operations ManagerReveal Email/Phone
4
Sr. Clinical Sample CoordinatorReveal Email/Phone
5
Material Handler, Warehouse LeadReveal Email/Phone
6
Business Systems AdministratorReveal Email/Phone
7
Clinical Laboratory LiaisonReveal Email/Phone
8
Senior Interface EngineerReveal Email/Phone
9
Sr.Medical Lab Scientist(ASCP)CMReveal Email/Phone
10
Assistant ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Sequenom?

SEQUENOM is a leading genetics company organized into two distinct business units: SEQUENOM Genetic Systems and SEQUENOM Pharmaceuticals. The two business units combine to capitalize on the Company's high performance DNA analysis platform, SNP assay portfolio, disease gene discovery programs and extensive DNA sample repository. SEQUENOM Genetic Systems is dedicated to the sales and support of the Company's MassARRAY products and the continual expansion of platform applications. SEQUENOM Pharmaceuticals applies the power of human genetics to systematically identify disease-related genes that affect significant portions of the overall population. The pharmaceutical unit focuses on disease gene discovery, target identification, functional validation and ultimately diagnostic and therapeutic product development.

keywords:Biotechnology

$185.3M

Total Funding

170

Number of Employees

$300M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sequenom News

2022-04-19 - Cell-Free DNA (cfDNA) Testing Market 2022 – 2028: Current ...

... 2028: Current and Future Opportunities for Key Players, With Covid-19 Impact Analysis: Sequenom, Inc., Quest Diagnostics, Illumina Inc.

2022-04-17 - Global Prenatal Genetic Testing Market 2022-2028 (Impact of ...

Global Prenatal Genetic Testing Market 2022-2028 (Impact of Covid-19) | Sequenom Laboratories, Illumina, Natera, Ariosa Diagnostics, BGI Health.

2022-04-13 - Non-Invasive Prenatal Testing Market in-depth Summary ...

... in-depth Summary, Growth Factors, Regional Analysis and Forecasts Outlook 2028: Natera, Illumina, Sequenom, Roche, Quest Diagnostics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A174-8%N/A
#2
$30.1M189-8%N/A
#3
$35M2072%N/A
#4
$37.3M22615%N/A
#5
$57.4M2377%N/A